Monday, May 04, 2020 5:57:29 PM
Senti.
Your analysis however fails to recognize that the one person who controls the price of the stock in the short term and in the long term is LP.
So she could for sure make the stock not spike or be valuable during her six month Non-exercise time. When she cannot exercise her options.
How do you say? Anytime there’s a little spike in the stock price she will just do a dilution at well below the market value and well below the price.
It’s not like you or I gave up an option to sell our stock during the six Month. In time. Oh no this is CEO LP who absolutely knows all of the details and has insider knowledge and has the ability to that will dilute the stock to keep the price down.
Hence she’s “giving up” something that she has Absolute total control of therefore the value “consideration” of her giving up this six months time, when she cannot exercise, is not very much.
Especially when you consider she gets A very valuable full 2 1/2 years after the six months in time value for her warrants.
It seems that you will defend LP at any cost no matter how egregious the items and the things that she does. This being probably the newest and most poignant example.
I just hope that she hasn’t done this for all of the warrant holders there by really taking it to us long-suffering retail long’s.
Your analysis however fails to recognize that the one person who controls the price of the stock in the short term and in the long term is LP.
So she could for sure make the stock not spike or be valuable during her six month Non-exercise time. When she cannot exercise her options.
How do you say? Anytime there’s a little spike in the stock price she will just do a dilution at well below the market value and well below the price.
It’s not like you or I gave up an option to sell our stock during the six Month. In time. Oh no this is CEO LP who absolutely knows all of the details and has insider knowledge and has the ability to that will dilute the stock to keep the price down.
Hence she’s “giving up” something that she has Absolute total control of therefore the value “consideration” of her giving up this six months time, when she cannot exercise, is not very much.
Especially when you consider she gets A very valuable full 2 1/2 years after the six months in time value for her warrants.
It seems that you will defend LP at any cost no matter how egregious the items and the things that she does. This being probably the newest and most poignant example.
I just hope that she hasn’t done this for all of the warrant holders there by really taking it to us long-suffering retail long’s.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
